SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John J. Frawley who wrote (1789)4/13/1999 11:08:00 PM
From: Marshall Teitelbaum  Read Replies (1) of 2205
 
John,

One other thing to consider....funded ATIS study just hit The Journal of Bone and Joint Surgery.

"A living cartilage/bone construct developed and maintained its structure throughout the 40-week study, and provides evidence that whole joint structures can potentially be created by using a combination of cells and biodegradable polymers. The success of this research helps to demonstrate the feasibility of replacing total joints with living tissue engineered constructs in the future."

Extremely interesting, especially for the long-term. There should be little need for artificial joints 10 years and beyond from now if all pans out, except maybe in acute situations. Of course, managed care on the other hand.......We'll cover a right knee, but no left knees unless you can show us that a right knee has failed first! :)

Regards,

Marshall
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News